Pancreatic Cancer
A Phase 1b/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (Ideate-Pantumor02) (DS7300-203)
- Details
ClinicalTrials.gov ID:
NCT06330064
Diagnosis Type:
NA
USOR Number:
- Address
,
P: